Joinn Biologics
JOINN Biologics: Premier CDMO provider for biotech & pharmaceuticals, offering end-to-end development and manufacturing services.
Founded
2018JOINN Biologics: Premier CDMO provider for biotech & pharmaceuticals, offering end-to-end development and manufacturing services.
Founded in the California Bay Area, JOINN Biologics is dedicated to advancing biotechnology and biopharmaceuticals through its premier contract development and manufacturing organization (CDMO) services. The company’s core mission is to support drug discovery and development by providing a comprehensive range of services from early-stage development to clinical manufacturing. JOINN Biologics focuses on biologics and advanced therapies, catering to biotech and pharmaceutical companies on a global scale.
Notable for its affiliation with the JOINN Family, which boasts over 20 years of success in drug discovery and development, JOINN Biologics has established itself as a key player in the industry. The company has achieved significant milestones in supporting numerous biotech and pharmaceutical projects, contributing to the advancement of innovative therapies. With a strong track record and a commitment to excellence, JOINN Biologics continues to make a substantial impact on the global healthcare landscape.
Companies similar to Joinn Biologics include Societal Cdmo, August Bioservices, JK BioPharma Solutions and NJ Bio.
Joinn Biologics was founded in 2018.
Joinn Biologics' headquarters is located in Richmond, CA, US.
Joinn Biologics' most recent funding round was for $150M (USD) in August 2021.
As of Aug 1, 2021, Joinn Biologics has disclosed funding of $210M (USD). Undisclosed round amounts are excluded.
Joinn Biologics has 375 employees as of Feb 4, 2024.
NJ Bio
njbio.com
